Elevated serum β2M level can also be seen in patients with solid cancers, such as ovarian cancer (293), gall bladder cancer (294), prostate cancer (295), breast cancer (296), and renal cell carcinoma (297). The gene discussed is B2M; the disease is ovarian cancer.